BDSX Stock Analysis: Buy, Sell, or Hold?
BDSX - Biodesix, Inc. Common Stock
$14.17
-0.59 (-4.00%)
▼
5d:
-7.51%
30d:
+6.46%
90d:
+23.76%
HOLD
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 04, 2026
0d
Get Alerted When BDSX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BDSX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BDSX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BDSX is currently trading at $14.17, which is considered slightly high relative to its 30-day fair value range of $10.99 to $14.84.
Technical Outlook: Technically, BDSX is in a strong uptrend. Immediate support is located at $10.73, while resistance sits at $16.50. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: BDSX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $30.50 (+115.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BDSX is in a strong uptrend. Immediate support is located at $10.73, while resistance sits at $16.50. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: BDSX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $30.50 (+115.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$10.99 -
$14.84
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.7%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.0%)
- BULLISH: Trading 115.2% below Wall St target ($30.50)
- CAUTION: Recommendation downgraded due to -7.5% 5-day decline
Trading Range Analysis
30-Day Trading Range
$10.99 -
$14.84
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$10.73
Resistance Level
$16.50
Current Trend
Strong Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.78
Wall Street Target
$30.50
(+115.2%)
Revenue Growth (YoY)
42.3%
Profit Margin
-33.3%
Share & Embed Analysis
Last updated: May 18, 2026 7:05 AM ET
Data refreshes hourly during market hours. Next update: 8:05 AM
Data refreshes hourly during market hours. Next update: 8:05 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BDSX showing a specific setup today?
Insider Activity (6 Months)
3
Buys
15
Sells
Net
INSIDERS SELLING
Recent Transactions
Gary Anthony Pestano
SELL
556 shares
2026-02-23
Kieran O'kane
SELL
535 shares
2026-02-23
Robin Harper Cowie
SELL
535 shares
2026-02-23
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$613 | 54 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$248 | 53 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$131 | 60 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 49 HOLD |
